SEC Company Response from IN8BIO, (INAB) — Jan 26, 2026
IN8BIO, INC.
Date: Jan. 26, 2026 · CIK: 0001740279 · Accession: 0001193125-26-022614
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292830
Letter
RE: IN8bio, Inc. Registration Statement on Form S-3 File No. 333-292830 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, IN8bio, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on January 28, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Jaime L. Chase and Trey Reilly of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Jaime L. Chase at (202) 728-7096 or, in her absence, Trey Reilly of Cooley LLP, counsel to the Registrant, at (212) 479-6502.
IN8bio, Inc. 350 5th Avenue, Suite 5330 New York, New York 10118 January 26, 2026 VIA EDGAR Division of Corporation Finance Office of Technology United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C.
Very truly yours,
IN8BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP IN8bio, Inc. 350 5th Avenue, Suite 5330 New York, New York 10118 January 26, 2026 VIA EDGAR Division of Corporation Finance Office of Technology United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 RE: IN8bio, Inc. Registration Statement on Form S-3 File No. 333-292830 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, IN8bio, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on January 28, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Jaime L. Chase and Trey Reilly of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Jaime L. Chase at (202) 728-7096 or, in her absence, Trey Reilly of Cooley LLP, counsel to the Registrant, at (212) 479-6502. Very truly yours, IN8BIO, INC. By: /s/ Patrick McCall Name: Patrick McCall Title: Chief Financial Officer cc: William Ho, IN8bio, Inc. Jaime L. Chase, Cooley LLP Trey Reilly, Cooley LLP